Skip to main content
Top
Published in: Advances in Therapy 2/2020

Open Access 01-02-2020 | Original Research

Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal

Authors: Nermina Ferizović, Jade Marshall, Angela E. Williams, M. Zulf Mughal, Nicholas Shaw, Catherine Mak, Oliver Gardiner, Pushpa Hossain, Sheela Upadhyaya

Published in: Advances in Therapy | Issue 2/2020

Login to get access

Abstract

Introduction

Capturing the patient experience of living with a rare disease such as X-linked hypophosphataemia (XLH) is critical for a holistic understanding of the burden of a disease. The complexity of the disease coupled with the limited population makes elicitation of the patient burden methodologically challenging. This study used qualitative information direct from patient and caregiver statements to assess the burden of XLH.

Methods

A thematic analysis was conducted on statements received during a National Institute for Health and Care Excellence (NICE) online public open consultation from 15 June to 6 July 2018. Researchers and clinical experts generated themes and codes based on expected aspects of XLH burden. Statements were independently coded by two reviewers, adding additional codes as required, and analysed by frequency and co-reporting across age groups.

Results

The majority of responses were submitted from UK-based patients with some from the USA and Australia, and the statements related to children, adolescents and adults. The findings suggest that the greatest burden experienced by children is associated with conventional therapy, co-reported with dosing regimen, adherence, distress and pain. During adolescence, the burden becomes increasingly complex and multi-factorial, with an increasing psychological burden. In adults, conventional therapy co-reported with bone deformity and orthopaedic surgery, as well as pain, mobility, fatigue and dental problems, featured highly.

Discussion

Whilst our study was opportunistic in nature, it has highlighted the clear and distinctive evolution of the burden of XLH, transitioning from being therapy-oriented in childhood to multi-factorial in adolescence, and finally to adulthood with its high impact on need for other interventions, function and mobility. This qualitative thematic analysis enhances the understanding of the symptom and treatment burden of XLH.
Literature
1.
go back to reference Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26:1381–8.CrossRef Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26:1381–8.CrossRef
2.
go back to reference Linglart A, Biosse-Duplan M, Briot K, et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect. 2014;3:R13–30.CrossRef Linglart A, Biosse-Duplan M, Briot K, et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect. 2014;3:R13–30.CrossRef
3.
go back to reference Carpenter TO, Whyte MP, Imel EA, et al. Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med. 2018;378:1987–98.CrossRef Carpenter TO, Whyte MP, Imel EA, et al. Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med. 2018;378:1987–98.CrossRef
5.
go back to reference Wagener JS, Millar SJ, Mayer-Hamblett N, et al. Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation. J Cystic Fibrosis. 2018;17:503–10.CrossRef Wagener JS, Millar SJ, Mayer-Hamblett N, et al. Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation. J Cystic Fibrosis. 2018;17:503–10.CrossRef
8.
go back to reference Beck-Nielsen SS, Mughal Z, Haffner D, et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis. 2019;14:58.CrossRef Beck-Nielsen SS, Mughal Z, Haffner D, et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis. 2019;14:58.CrossRef
10.
go back to reference Mills ES, Iorio L, Feinn RS, Duignan KM, Macica CM. Joint replacement in X-linked hypophosphatemia. J Orthop. 2019;16:55–60.CrossRef Mills ES, Iorio L, Feinn RS, Duignan KM, Macica CM. Joint replacement in X-linked hypophosphatemia. J Orthop. 2019;16:55–60.CrossRef
12.
go back to reference Guerboub AA, Moussaoui S, Issouani J, Errahali Y, Belmejdoub G. X-linked vitamin d-resistant rickets: 12 years of follow-up. Pan Afr Med J. 2018;30:9.CrossRef Guerboub AA, Moussaoui S, Issouani J, Errahali Y, Belmejdoub G. X-linked vitamin d-resistant rickets: 12 years of follow-up. Pan Afr Med J. 2018;30:9.CrossRef
13.
go back to reference Lin X, Zhu Y, Luo J, Huang J. Genetic analysis of three families with X-linked dominant hypophosphatemic rickets. J Pediatr Endocrinol Metab. 2018;31:789–97.CrossRef Lin X, Zhu Y, Luo J, Huang J. Genetic analysis of three families with X-linked dominant hypophosphatemic rickets. J Pediatr Endocrinol Metab. 2018;31:789–97.CrossRef
14.
go back to reference Coyac BR, Falgayrac G, Penel G, et al. Impaired mineral quality in dentin in X-linked hypophosphatemia. Connect Tissue Res. 2018;59:91–6.CrossRef Coyac BR, Falgayrac G, Penel G, et al. Impaired mineral quality in dentin in X-linked hypophosphatemia. Connect Tissue Res. 2018;59:91–6.CrossRef
15.
go back to reference Acar S, BinEssa HA, Demir K, et al. Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: novel mutations in PHEX and SLC34A3. PLoS One. 2018;13:e0193388.CrossRef Acar S, BinEssa HA, Demir K, et al. Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: novel mutations in PHEX and SLC34A3. PLoS One. 2018;13:e0193388.CrossRef
16.
go back to reference Chesher D, Oddy M, Darbar U, et al. Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations. J Inherit Metab Dis. 2018;41:865–76.CrossRef Chesher D, Oddy M, Darbar U, et al. Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations. J Inherit Metab Dis. 2018;41:865–76.CrossRef
17.
go back to reference Liao H, Zhu HM, Liu HQ, Li LP, Liu SL, Wang H. Two novel variants of the PHEX gene in patients with Xlinked dominant hypophosphatemic rickets and prenatal diagnosis for fetuses in these families. Int J Mol Med. 2018;41:2012–20.PubMedPubMedCentral Liao H, Zhu HM, Liu HQ, Li LP, Liu SL, Wang H. Two novel variants of the PHEX gene in patients with Xlinked dominant hypophosphatemic rickets and prenatal diagnosis for fetuses in these families. Int J Mol Med. 2018;41:2012–20.PubMedPubMedCentral
18.
go back to reference Thacher TD, Pettifor JM, Tebben PJ, et al. Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: utility of the radiographic Rickets Severity Score. Bone. 2019;122:76–81.CrossRef Thacher TD, Pettifor JM, Tebben PJ, et al. Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: utility of the radiographic Rickets Severity Score. Bone. 2019;122:76–81.CrossRef
19.
go back to reference Tokarz D, Martins JS, Petit ET, Lin CP, Demay MB, Liu ES. Hormonal regulation of osteocyte perilacunar and canalicular remodeling in the hyp mouse model of X-linked hypophosphatemia. J Bone Miner Res. 2018;33:499–509.CrossRef Tokarz D, Martins JS, Petit ET, Lin CP, Demay MB, Liu ES. Hormonal regulation of osteocyte perilacunar and canalicular remodeling in the hyp mouse model of X-linked hypophosphatemia. J Bone Miner Res. 2018;33:499–509.CrossRef
20.
go back to reference Zhang C, Zhao Z, Sun Y, et al. Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone. 2019;121:212–20.CrossRef Zhang C, Zhao Z, Sun Y, et al. Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone. 2019;121:212–20.CrossRef
21.
go back to reference Theodore-Oklota C, Bonner N, Spencer H, Arbuckle R, Chen CY, Skrinar A. Qualitative research to explore the patient experience of X-linked hypophosphatemia and evaluate the suitability of the BPI-SF and WOMAC(R) as clinical trial end points. Value Health. 2018;21:973–83.CrossRef Theodore-Oklota C, Bonner N, Spencer H, Arbuckle R, Chen CY, Skrinar A. Qualitative research to explore the patient experience of X-linked hypophosphatemia and evaluate the suitability of the BPI-SF and WOMAC(R) as clinical trial end points. Value Health. 2018;21:973–83.CrossRef
22.
go back to reference Castleberry A, Nolen A. Thematic analysis of qualitative research data: Is it as easy as it sounds? Curr Pharm Teach Learn. 2018;10:807–15.CrossRef Castleberry A, Nolen A. Thematic analysis of qualitative research data: Is it as easy as it sounds? Curr Pharm Teach Learn. 2018;10:807–15.CrossRef
23.
go back to reference Shenton A. Strategies for ensuring trustworthiness in qualitative research projects. Educ Inf. 2004;22:63–75. Shenton A. Strategies for ensuring trustworthiness in qualitative research projects. Educ Inf. 2004;22:63–75.
24.
go back to reference Schwandt T, Lincoln Y, Guba E. Judging interpretations: but is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Dir Evaluat Wiley-Blackwell. 2007;114:11–25.CrossRef Schwandt T, Lincoln Y, Guba E. Judging interpretations: but is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Dir Evaluat Wiley-Blackwell. 2007;114:11–25.CrossRef
25.
go back to reference Skrinar A, Dvorak-Ewell M, Evins A, et al. The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocrine Soc. 2019;3:1321–34.CrossRef Skrinar A, Dvorak-Ewell M, Evins A, et al. The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocrine Soc. 2019;3:1321–34.CrossRef
26.
go back to reference Guba EG. ERIC/ECTJ annual review paper: criteria for assessing the trustworthiness of naturalistic inquiries. J Educ Commun Technol. 1981;29:75–91. Guba EG. ERIC/ECTJ annual review paper: criteria for assessing the trustworthiness of naturalistic inquiries. J Educ Commun Technol. 1981;29:75–91.
Metadata
Title
Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal
Authors
Nermina Ferizović
Jade Marshall
Angela E. Williams
M. Zulf Mughal
Nicholas Shaw
Catherine Mak
Oliver Gardiner
Pushpa Hossain
Sheela Upadhyaya
Publication date
01-02-2020
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 2/2020
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-019-01193-0

Other articles of this Issue 2/2020

Advances in Therapy 2/2020 Go to the issue